North Texas Pharmacy Researchers Awarded CPRIT Funding
The Cancer Prevention & Research Institute of Texas (CPRIT) announced Sept. 14 it was awarding a $2.5 million grant to Richard Leff, Pharm.D.,
and the North Texas Clinical Pharmacology Cancer Core, a group of researchers from
the Texas Tech University Health Sciences Center (TTUHSC) School of Pharmacy campus in Dallas.
Leff, a professor for TTUHSC’s Department of Pharmacy Practice and senior associate dean for the School of Pharmacy’s clinical and translational research, said there is urgent need for translating basic cancer research discoveries into improved care for cancer patients and better interventional tools to cure and prevent cancer. To assist basic cancer researchers and physicians in developing better methods for testing new cancer drugs and cancer treatment therapies that result from these efforts, Leff and a team of TTUHSC School of Pharmacy collaborators have established the North Texas Clinical Pharmacology Cancer Core, a state-of-the-art analytical facility operating in the Dallas Medical District.
“Our team has expertise and state-of-the-art instrumentation to help cancer investigators with designing studies to optimize our understanding of drug movement in the body, the action of drugs and the best approaches to administer the drug and enhance cures while reducing unwanted side effects,” Leff said.
Such testing, Leff added, will assist investigators to better understand how cancer drugs work in the body, how the drugs treat cancer and how to avoid unwanted effects of cancer drugs.
“In general, the research team of this core will support translational researchers to do research on what cancer drugs do to the body and what the human body does to the drugs,” Leff said. “Continued funding will keep the Clinical Pharmacology Cancer Core open and operational, upgrade our laboratory and expand our research capacity and capability to meet clinical pharmacology needs of North Texas cancer investigators.”
The Clinical Pharmacology Cancer Core includes Claudia Meek, Ph.D., Carlos Alvarez, Pharm.D., and Ronald Hall, Pharm.D., from the TTUHSC School of Pharmacy campus in Dallas; and Paul Trippier, Ph.D., from the TTUHSC campus in Amarillo.
Related Stories
Noise-Induced Hearing Loss in Rural Adolescents
Leigh Ann Reel, Au.D., Ph.D., CCC-A, discussed the causes and prevention strategies for noise-induced hearing loss, particularly for adolescents in rural areas.
Willed Body Memorial Service Honors Those Who Donated
On Memorial Day each May, a service is conducted at the Texas Tech University Health Sciences Center Institute of Anatomical Sciences to pay respect to the Willed Body Program donors and their families.
Molecular Pathology Preceptorship: Unmatched Value and Experience
Ericka Hendrix, PhD, MB(ASCP)CM, Program Director and Associate Professor in the Master of Science in Molecular Pathology program in the School of Health Professions spoke about the program’s preceptorship.
Recent Stories
TTUHSC Receives $1.3 Million HRSA Telehealth Resource Center Grant to Expand Telehealth in Texas and Louisiana
The TexLa Telehealth Resource Center, based at TTUHSC, has been awarded a $1.3 million, four-year grant from HRSA to strengthen and expand digital health services in Texas and Louisiana.
The Relational Health Center Celebrates Two Years of Care for Families
On Friday, August 22, from 3 - 5 p.m., the Relational Health Center is celebrating its second birthday with an open house event at Covenant Children’s Hospital in Lubbock.
From Backpacks to White Coats: TTUHSC School of Medicine Invests in Tomorrow’s Healers Today
As part of its partnership with JAMP, the TTUHSC School of Medicine Admissions Office recently partnered with Alderson Elementary School in the Lubbock Independent School District to provide critical school supplies.